NUVB logo

Nuvation Bio Inc. (NUVB) Cash From Financing

Annual CFF:

$331.00K-$297.00K(-47.29%)
December 31, 2024

Summary

  • As of today, NUVB annual cash from financing is $331.00 thousand, with the most recent change of -$297.00 thousand (-47.29%) on December 31, 2024.
  • During the last 3 years, NUVB annual cash from financing has fallen by -$625.20 million (-99.95%).
  • NUVB annual cash from financing is now -99.95% below its all-time high of $625.53 million, reached on December 31, 2021.

Performance

1-Year Change

-47.29%

3-Year Change

-99.95%

5-Year Change

-99.75%

15-Year Change

-99.75%

NUVB Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

29.71%
NUVB annual cash from financing is higher than 29.71% of companies in Healthcare sector

Range

All-Time High

$625.53M
NUVB annual cash from financing is currently -99.95% below its historical high of $625.53 million

3-Year Low

$331.00K
NUVB annual cash from financing is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
NUVB previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Mar 5, 2026
NUVB next annual earnings announcement is scheduled for Mar 5, 2026

OtherNUVBcash flow metrics

Annual CFI

$122.70M
NUVB annual cash from investing is $122.70 million

Annual CFO

-$130.41M
NUVB annual cash from operations is -$130.41 million

Annual FCF

-$130.57M
NUVB annual free cash flow is -$130.57 million

Annual CAPEX

$162.00K
NUVB annual capital expenditures is $162.00 thousand

Quarterly CFF:

$501.00K-$192.92M(-99.74%)
September 30, 2025

Summary

  • As of today, NUVB quarterly cash from financing is $501.00 thousand, with the most recent change of -$192.92 million (-99.74%) on September 30, 2025.
  • Over the past year, NUVB quarterly cash from financing has increased by +$2.04 million (+132.57%).
  • NUVB quarterly cash from financing is now -99.92% below its all-time high of $624.96 million, reached on March 31, 2021.

Performance

3-Month Change

-99.74%

1-Year Change

+132.57%

3-Year Change

+94.19%

5-Year Change

+0.2%

NUVB Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

53.87%
NUVB quarterly cash from financing is higher than 53.87% of companies in Healthcare sector

Range

All-Time High

$624.96M
NUVB quarterly cash from financing is currently -99.92% below its historical high of $624.96 million

3-Year Low

-$1.54M
NUVB quarterly cash from financing is currently +132.57% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
NUVB previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 5, 2026
NUVB next earnings announcement is scheduled for Mar 5, 2026

OtherNUVBcash flow metrics

Quarterly CFI

-$96.62M
NUVB quarterly cash from investing is -$96.62 million

Quarterly CFO

-$52.89M
NUVB quarterly cash from operations is -$52.89 million

Quarterly FCF

-$60.90M
NUVB quarterly free cash flow is -$60.90 million

Quarterly CAPEX

$8.01M
NUVB quarterly capital expenditures is $8.01 million

TTM CFF:

$193.57M+$2.04M(+1.06%)
September 30, 2025

Summary

  • As of today, NUVB TTM cash from financing is $193.57 million, with the most recent change of +$2.04 million (+1.06%) on September 30, 2025.
  • Over the past year, NUVB TTM cash from financing has increased by +$192.22 million (+14228.05%).
  • NUVB TTM cash from financing is now -74.47% below its all-time high of $758.16 million, reached on June 30, 2021.

Performance

3-Month Change

+1.06%

1-Year Change

+14228.05%

3-Year Change

+13176.54%

5-Year Change

+38614.4%

NUVB TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

92.16%
NUVB TTM cash from financing is higher than 92.16% of companies in Healthcare sector

Range

All-Time High

$758.16M
NUVB TTM cash from financing is currently -74.47% below its historical high of $758.16 million

3-Year Low

-$2.64M
NUVB TTM cash from financing is currently +7435.05% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
NUVB previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 5, 2026
NUVB next earnings announcement is scheduled for Mar 5, 2026

OtherNUVBcash flow metrics

TTM CFI

$64.21M
NUVB TTM cash from investing is $64.21 million

TTM CFO

-$190.00M
NUVB TTM cash from operations is -$190.00 million

TTM FCF

-$198.25M
NUVB TTM free cash flow is -$198.25 million

TTM CAPEX

$8.28M
NUVB TTM capital expenditures is $8.28 million

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

NUVB Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-47.3%+132.6%+10000.0%
3Y3 Years-100.0%+94.2%+10000.0%
5Y5 Years-99.8%+0.2%+10000.0%

NUVB Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-100.0%at low-99.7%+132.6%at high+7435.1%
5Y5-Year-100.0%at low-99.9%+113.9%-74.5%+7435.1%
All-TimeAll-Time-100.0%at low-99.9%+113.9%-74.5%+7435.1%

NUVB Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
$501.00K(-99.7%)
$193.57M(+1.1%)
Jun 2025
-
$193.42M(>+9900.0%)
$191.53M(>+9900.0%)
Mar 2025
-
$548.00K(+160.9%)
$858.00K(+159.2%)
Dec 2024
$331.00K(-47.3%)
-$900.00K(+41.5%)
$331.00K(-75.5%)
Sep 2024
-
-$1.54M(-156.0%)
$1.35M(-54.5%)
Jun 2024
-
$2.75M(>+9900.0%)
$2.97M(+745.0%)
Mar 2024
-
$21.00K(-82.5%)
$351.00K(-44.1%)
Dec 2023
$628.00K(-52.7%)
$120.00K(+55.8%)
$628.00K(-31.4%)
Sep 2023
-
$77.00K(-42.1%)
$915.00K(-16.5%)
Jun 2023
-
$133.00K(-55.4%)
$1.10M(+141.5%)
Mar 2023
-
$298.00K(-26.8%)
-$2.64M(-298.9%)
DateAnnualQuarterlyTTM
Dec 2022
$1.33M(-99.8%)
$407.00K(+57.8%)
$1.33M(-9.0%)
Sep 2022
-
$258.00K(+107.2%)
$1.46M(+24.8%)
Jun 2022
-
-$3.60M(-184.5%)
$1.17M(-75.8%)
Mar 2022
-
$4.26M(+692.6%)
$4.83M(-99.2%)
Dec 2021
$625.53M(+369.8%)
$538.00K(+1781.3%)
$625.53M(-17.4%)
Sep 2021
-
-$32.00K(-156.1%)
$757.62M(-0.1%)
Jun 2021
-
$57.00K(-100.0%)
$758.16M(+0.0%)
Mar 2021
-
$624.96M(+371.2%)
$758.10M(+469.4%)
Dec 2020
$133.13M
$132.63M(>+9900.0%)
$133.13M(>+9900.0%)
Sep 2020
-
$500.00K(>+9900.0%)
$500.00K(>+9900.0%)
Jun 2020
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2020
-
$0.00
$0.00

FAQ

  • What is Nuvation Bio Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for Nuvation Bio Inc.?
  • What is Nuvation Bio Inc. annual cash from financing year-on-year change?
  • What is Nuvation Bio Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Nuvation Bio Inc.?
  • What is Nuvation Bio Inc. quarterly cash from financing year-on-year change?
  • What is Nuvation Bio Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for Nuvation Bio Inc.?
  • What is Nuvation Bio Inc. TTM cash from financing year-on-year change?

What is Nuvation Bio Inc. annual cash from financing?

The current annual cash from financing of NUVB is $331.00K

What is the all-time high annual cash from financing for Nuvation Bio Inc.?

Nuvation Bio Inc. all-time high annual cash from financing is $625.53M

What is Nuvation Bio Inc. annual cash from financing year-on-year change?

Over the past year, NUVB annual cash from financing has changed by -$297.00K (-47.29%)

What is Nuvation Bio Inc. quarterly cash from financing?

The current quarterly cash from financing of NUVB is $501.00K

What is the all-time high quarterly cash from financing for Nuvation Bio Inc.?

Nuvation Bio Inc. all-time high quarterly cash from financing is $624.96M

What is Nuvation Bio Inc. quarterly cash from financing year-on-year change?

Over the past year, NUVB quarterly cash from financing has changed by +$2.04M (+132.57%)

What is Nuvation Bio Inc. TTM cash from financing?

The current TTM cash from financing of NUVB is $193.57M

What is the all-time high TTM cash from financing for Nuvation Bio Inc.?

Nuvation Bio Inc. all-time high TTM cash from financing is $758.16M

What is Nuvation Bio Inc. TTM cash from financing year-on-year change?

Over the past year, NUVB TTM cash from financing has changed by +$192.22M (+14228.05%)
On this page